会议播报|老问题新治疗，夏荔芪为前列腺疾病提供创新诊疗策略

Core Viewpoint - The "Chronic Disease Prevention and Treatment in China" academic conference held on May 18 highlighted the significant advancements in the treatment of prostate diseases, particularly through the innovative use of Xia Li Qi capsules, which have shown promising results in alleviating lower urinary tract symptoms (LUTS) associated with prostate conditions [1][3][4] Group 1: Prostate Disease Prevalence and Impact - Prostate diseases, such as benign prostatic hyperplasia (BPH), have a high incidence rate that severely affects male health, with approximately 20% of men aged 51-60, 50% of those aged 61-70, and 83% of men aged 81-90 being affected [3] - LUTS are common among BPH patients, with 90% of men aged 45-80 experiencing these symptoms, which include urinary frequency, urgency, incontinence, and nocturia [3] Group 2: Treatment Approaches and Innovations - For patients without surgical indications, the primary treatment for LUTS is medication; however, current conventional Western medications have limitations in safety and efficacy, necessitating better treatment options [3] - Xia Li Qi capsules, guided by the theory of "Luo Disease," combine "promoting, supplementing, and transforming" principles, offering advantages over traditional heat-clearing and dampness-dispelling methods [3][4] Group 3: Clinical Research and Efficacy - Research indicates that Xia Li Qi capsules significantly improve LUTS, delay disease progression, and enhance patients' quality of life, demonstrating good safety profiles [4] - Clinical studies confirm that Xia Li Qi capsules can reduce the International Prostate Symptom Score (IPSS) and improve urinary flow rates, with additional benefits when combined with medications like Tamsulosin and Finasteride [4] - Xia Li Qi capsules are classified as a Category B drug under medical insurance and are recommended in various clinical guidelines, providing new treatment options for prostate disease patients [4]